Richard Dilon (Richard Dillon)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 49

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood

Nature communications

Leukemia

Guy's and St Thomas' NHS Foundation Trust

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Guy's and St Thomas' NHS Foundation Trust May 01 2016

United Kingdom

Consultant Haematologist :: Department of Haematology

Kings College London Jan 05 2016

United Kingdom

Clinical Senior Lecturer :: Department of Medical and Molecular Genetics

Publications

Stuart Scott, Alison Devonshire, Richard Dilon, Christian Thiede, Nicholas C P Cross, Helen E White, Leandro Lo Cascio, Katya Mokretar, Nicola Potter, Christopher S Hourigan, Jerald P Radich, Adam Corner, Véronique Laloux, Gemma Halliday, Daniel Dilks, Tom Morrison, Katelyn Gilmour, Ashley Cartwright, Liam Whitby
Recommendations from the AML molecular MRD expert advisory board. Leukemia 38 (7) (2024)
Ing Soo Tiong, Devendra K Hiwase, Emad Abro, Ashish Bajel, Emma Palfreyman, Ashanka Beligaswatte, John Reynolds, Natasha S Anstee, Tamia Nguyen, Sun Loo, Chong Chyn Chua, Michael Ashby, Kaitlyn M Wiltshire, Shaun Fleming, Chun Yew Fong, Tse-Chieh Teh, Piers Blombery, Richard Dilon, Adam Ivey, Andrew H Wei
Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Frances Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, James Durrell Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan K Burnett, Charlotte S Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Post induction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood (2024)
Stuart Scott, Alison Devonshire, Richard Dilon, Christian Thiede, Nicholas C P Cross, Helen E White, Leandro Lo Cascio, Katya Mokretar, Nicola Potter, Christopher S Hourigan, Jerald P Radich, Adam Corner, Véronique Laloux, Gemma Halliday, Daniel Dilks, Tom Morrison, Katelyn Gilmour, Ashley Cartwright, Liam Whitby
Recommendations from the AML molecular MRD expert advisory board. Leukemia (2024)
Ing Soo Tiong, Devendra K Hiwase, Emad Abro, Ashish Bajel, Emma Palfreyman, Ashanka Beligaswatte, John Reynolds, Natasha S Anstee, Tamia Nguyen, Sun Loo, Chong Chyn Chua, Michael Ashby, Kaitlyn M Wiltshire, Shaun Fleming, Chun Yew Fong, Tse-Chieh Teh, Piers Blombery, Richard Dilon, Adam Ivey, Andrew H Wei
Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, Jamie Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Burnett, Charlotte Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood 143 (19) (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ing Soo Tiong, Devendra K Hiwase, Emad Abro, Ashish Bajel, Emma Palfreyman, Ashanka Beligaswatte, John Reynolds, Natasha S Anstee, Tamia Nguyen, Sun Loo, Chong Chyn Chua, Michael Ashby, Kaitlyn M Wiltshire, Shaun Fleming, Chun Yew Fong, Tse-Chieh Teh, Piers Blombery, Richard Dilon, Adam Ivey, Andrew H Wei
Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Stuart Scott, Alison Devonshire, Richard Dilon, Christian Thiede, Nicholas C P Cross, Helen E White, Leandro Lo Cascio, Katya Mokretar, Nicola Potter, Christopher S Hourigan, Jerald P Radich, Adam Corner, Véronique Laloux, Gemma Halliday, Daniel Dilks, Tom Morrison, Katelyn Gilmour, Ashley Cartwright, Liam Whitby
Recommendations from the AML molecular MRD expert advisory board. Leukemia 38 (7) (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, Jamie Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Burnett, Charlotte Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood 143 (19) (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, Jamie Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Burnett, Charlotte Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood 143 (19) (2024)
Stuart Scott, Alison Devonshire, Richard Dilon, Christian Thiede, Nicholas C P Cross, Helen E White, Leandro Lo Cascio, Katya Mokretar, Nicola Potter, Christopher S Hourigan, Jerald P Radich, Adam Corner, Véronique Laloux, Gemma Halliday, Daniel Dilks, Tom Morrison, Katelyn Gilmour, Ashley Cartwright, Liam Whitby
Recommendations from the AML molecular MRD expert advisory board. Leukemia 38 (7) (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ing Soo Tiong, Devendra K Hiwase, Emad Abro, Ashish Bajel, Emma Palfreyman, Ashanka Beligaswatte, John Reynolds, Natasha S Anstee, Tamia Nguyen, Sun Loo, Chong Chyn Chua, Michael Ashby, Kaitlyn M Wiltshire, Shaun Fleming, Chun Yew Fong, Tse-Chieh Teh, Piers Blombery, Richard Dilon, Adam Ivey, Andrew H Wei
Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Frances Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, James Durrell Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan K Burnett, Charlotte S Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Post induction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood (2024)
Ing Soo Tiong, Devendra K Hiwase, Emad Abro, Ashish Bajel, Emma Palfreyman, Ashanka Beligaswatte, John Reynolds, Natasha S Anstee, Tamia Nguyen, Sun Loo, Chong Chyn Chua, Michael Ashby, Kaitlyn M Wiltshire, Shaun Fleming, Chun Yew Fong, Tse-Chieh Teh, Piers Blombery, Richard Dilon, Adam Ivey, Andrew H Wei
Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Stuart Scott, Alison Devonshire, Richard Dilon, Christian Thiede, Nicholas C P Cross, Helen E White, Leandro Lo Cascio, Katya Mokretar, Nicola Potter, Christopher S Hourigan, Jerald P Radich, Adam Corner, Véronique Laloux, Gemma Halliday, Daniel Dilks, Tom Morrison, Katelyn Gilmour, Ashley Cartwright, Liam Whitby
Recommendations from the AML molecular MRD expert advisory board. Leukemia 38 (7) (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
William Villiers, Audrey Kelly, Xiaohan He, James Kaufman-Cook, Abdurrahman Elbasir, Halima Bensmail, Paul Lavender, Richard Dilon, Borbala Mifsud, Cameron S Osborne
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia. Nature communications 14 (1) (2023)
Brunangelo Falini, Richard Dilon
Criteria for diagnosis and molecular monitoring of NPM1-mutated AML. Blood cancer discovery (2023)
Carlos Jimenez Chillon, Jad Othman, David Taussig, Carlos Jiménez-Vicente, Alexandra Martínez-Roca, Ing Soo Tiong, Manish Jain, James Aries, Seda Cakmak, Stephen Knapper, Daniel Tuyet Kristensen, Vidhya Murthy, Zacharoula Galani, Charlotte Kallmeyer, Loretta Ngu, David Veale, Simon Bolam, Nina Orfali, Anne Parker, Cara Manson, Jane Parker, Thomas Erblich, Deborah Susan Richardson, Katya Mokretar, Nicola Potter, Ulrik Malthe Overgaard, Anne Stidsholt Roug, Andrew H Wei, Jordi Esteve, Martin Jädersten, Nigel H Russell, Richard Dilon
Venetoclax-based low intensity therapy in molecular failure of NPM1 mutated AML. Blood advances (2023)
Jad Othman, Charlotte S Wilhelm-Benartzi, Richard Dilon, Stephen Knapper, Sylvie D Freeman, Leona M Batten, Joanna Canham, Emily L Hinson, Julie Wych, Sophie Betteridge, William Villiers, Michelle Kleeman, Amanda Frances Gilkes, Nicola Potter, Ulrik Overgaard, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Jane Hemmaway, Claire Arnold, Mike Dennis, Nigel H Russell
A Randomised Comparison of CPX-351 and FLAG-Ida in Adverse Karyotype AML and High-Risk MDS: The UK NCRI AML19 Trial. Blood advances (2023)
William Villiers, Audrey Kelly, Xiaohan He, James Kaufman-Cook, Abdurrahman Elbasir, Halima Bensmail, Paul Lavender, Richard Dilon, Borbala Mifsud, Cameron S Osborne
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia. Nature communications 14 (1) (2023)
Justin Loke, Nicholas McCarthy, Aimee E Jackson, Shamyla Siddique, Andrea Hodgkinson, John Mason, Charles R Crawley, Maria Gilleece, Andrew J Peniket, Rachel Protheroe, Rahuman Salim, Eleni Tholouli, Keith M O Wilson, Georgia Andrew, Richard Dilon, Naeem Khan, Victoria Potter, Pramila Krishnamurthy, Charles Craddock, Sylvie D Freeman
Posttransplant MRD and T-cell chimerism status predict outcomes in patients allografted with AML/MDS. Blood advances (2023)
William Villiers, Audrey Kelly, Xiaohan He, James Kaufman-Cook, Abdurrahman Elbasir, Halima Bensmail, Paul Lavender, Richard Dilon, Borbala Mifsud, Cameron S Osborne
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia. Nature communications 14 (1) (2023)
William Villiers, Audrey Kelly, Xiaohan He, James Kaufman-Cook, Abdurrahman Elbasir, Halima Bensmail, Paul Lavender, Richard Dilon, Borbala Mifsud, Cameron S Osborne
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia. Nature communications 14 (1) (2023)
Jad Othman, Nicola Potter, Katya Mokretar, David Taussig, Anjum Khan, Pramila Krishnamurthy, Anne-Louise Latif, Paul Cahalin, James Aries, Mariam Amer, Edward Belsham, Eibhlin Conneally, Charles F Craddock, Dominic Culligan, Mike Dennis, Caroline Duncan, Sylvie D Freeman, Caroline Furness, Amanda Gilkes, Paraskevi Gkreka, Katherine Hodgson, Wendy Ingram, Manish Jain, Andrew King, Stephen Knapper, Panagiotis Kottaridis, Mary Frances Frances McMullin, Unmesh Mohite, Loretta Ngu, Jenny O'Nions, Katharine Patrick, Tom Rider, Wing Roberts, Marianne Tang Severinsen, Neill Storrar, Tom Taylor, Nigel H Russell, Richard Dilon
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML. Leukemia (2023)
William Villiers, Audrey Kelly, Xiaohan He, James Kaufman-Cook, Abdurrahman Elbasir, Halima Bensmail, Paul Lavender, Richard Dilon, Borbala Mifsud, Cameron S Osborne
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia. Nature communications 14 (1) (2023)
Jad Othman, Ing Soo Tiong, Jenny O'Nions, Mike Dennis, Katya Mokretar, Adam Ivey, Michael James Austin, Annie-Louise Latif, Mariam Amer, Wei Yee Chan, Charles R Crawley, Francesca Crolla, Joe Wilson Cross, Raymond Dang, Johnathon Elliot, Chun Yew Fong, Sofia Galli, Paolo Gallipoli, Francesca Hogan, Pallavi Kalkur, Anjum Bashir Khan, Pramila Krishnamurthy, John Laurie, Sun Loo, Scott Marshall, Priyanka Mehta, Vidhya Murthy, Sateesh K Nagumantry, Srinivas Pillai, Nicola Potter, Rob S Sellar, Thomas Taylor, Rui Zhao, Nigel H Russell, Andrew H Wei, Richard Dilon
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based non-intensive therapy. Blood (2023)
William Villiers, Audrey Kelly, Xiaohan He, James Kaufman-Cook, Abdurrahman Elbasir, Halima Bensmail, Paul Lavender, Richard Dilon, Borbala Mifsud, Cameron S Osborne
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia. Nature communications 14 (1) (2023)
William Villiers, Audrey Kelly, Xiaohan He, James Kaufman-Cook, Abdurrahman Elbasir, Halima Bensmail, Paul Lavender, Richard Dilon, Borbala Mifsud, Cameron S Osborne
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia. Nature communications 14 (1) (2023)
William Villiers, Audrey Kelly, Xiaohan He, James Kaufman-Cook, Abdurrahman Elbasir, Halima Bensmail, Paul Lavender, Richard Dilon, Borbala Mifsud, Cameron S Osborne
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia. Nature communications 14 (1) (2023)
Jad Othman, Manja Meggendorfer, Enrico Tiacci, Christian Thiede, Richard F Schlenk, Richard Dilon, Sebastian Stasik, Alessandra Venanzi, Sarah Bertoli, Eric Delabesse, Pierre-Yves Dumas, Arnaud Pigneux, Audrey Bidet, Amanda Frances Gilkes, Ian Thomas, Maria Teresa Teresa Voso, Alessandro Rambaldi, Lorenzo Brunetti, Vincenzo Maria Perriello, Vibeke Andresen, Bjorn T Gjertsen, Maria Paola Martelli, Christian Recher, Hubert Serve, Carsten Muller-Tidow, Claudia D Baldus, Torsten Haferlach, Nigel H Russell, Brunangelo Falini
Overlapping features of therapy-related and de novoNPM1-mutated AML. Blood (2022)
Richard Dilon, Shanna Maycock, Aimee Jackson, Sonia Fox, Sylvie Freeman, Charles Craddock, Catherine Thomas, Emma Homer, Jane Leahy, Anna Mamwell, Nicola Potter, Nigel Russell, Andrew Wei, Hans Beier Ommen, Claire Hemmaway, Steve Knapper, Lucinda Billingham
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial. BMC cancer 22 (1) (2022)
Jad Othman, Manja Meggendorfer, Enrico Tiacci, Christian Thiede, Richard F Schlenk, Richard Dilon, Sebastian Stasik, Alessandra Venanzi, Sarah Bertoli, Eric Delabesse, Pierre-Yves Dumas, Arnaud Pigneux, Audrey Bidet, Amanda Frances Gilkes, Ian Thomas, Maria Teresa Teresa Voso, Alessandro Rambaldi, Lorenzo Brunetti, Vincenzo Maria Perriello, Vibeke Andresen, Bjorn T Gjertsen, Maria Paola Martelli, Christian Recher, Christoph Röllig, Martin Bornhäuser, Hubert Serve, Carsten Muller-Tidow, Claudia D Baldus, Torsten Haferlach, Nigel H Russell, Brunangelo Falini
Overlapping features of therapy-related and de novoNPM1-mutated AML. Blood (2022)
Harry J Iland, Nigel H Russell, Richard Dilon, Andre C Schuh, Aditya Tedjaseputra, Andrew H Wei, Asim Khwaja, Steven Knapper, Steven W Lane, John Reynolds, Mary Frances Frances McMullin, Annalise Maria Martin, Peter Tan, David Christopher C Taussig, Anny Wong, John M Taper, Christina Fraga, Richard Kelly, Kiran Tawana, Priyanka Mehta, Alain Mina, Jessica K Altman, Ingolf Mølle, Sudhir Tauro, Eleni Tholouli
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation. Blood advances (2022)
Jad Othman, Manja Meggendorfer, Enrico Tiacci, Christian Thiede, Richard F Schlenk, Richard Dilon, Sebastian Stasik, Alessandra Venanzi, Sarah Bertoli, Eric Delabesse, Pierre-Yves Dumas, Arnaud Pigneux, Audrey Bidet, Amanda Frances Gilkes, Ian Thomas, Maria Teresa Teresa Voso, Alessandro Rambaldi, Lorenzo Brunetti, Vincenzo Maria Perriello, Vibeke Andresen, Bjorn T Gjertsen, Maria Paola Martelli, Christian Recher, Christoph Röllig, Martin Bornhäuser, Hubert Serve, Carsten Muller-Tidow, Claudia D Baldus, Torsten Haferlach, Nigel H Russell, Brunangelo Falini
Overlapping features of therapy-related and de novoNPM1-mutated AML. Blood (2022)
Diego Antonio Pereira-Martins, Juan L Coelho-Silva, Isabel Weinhäuser, Pedro L Franca-Neto, Douglas Rafaele Almeida Silveira, César Ortiz, Amanda Moreira-Aguiar, Marinus M Lima, Luisa C Koury, Raul A de Melo, Ana B Glória, Evandro M Fagundes, Bruno Kosa L Duarte, Katia B B Pagnano, Rosane Bittencourt, Elenaide Nunes, Fabiola Traina, Lorena Figueiredo-Pontes, Armand Keating, Martin S Tallman, Raul C Ribeiro, Richard Dilon, Arnold Ganser, Miguel A Sanz, Nancy Berliner, Peter Valk, Bob Löwenberg, Tiziana Ottone, Nelida Inés Noguera, Maria Teresa Teresa Voso, Francesca Paoloni, Paola Fazi, Emanuele Ammatuna, Gerwin Huls, Jan Jacob Schuringa, Eduardo Magalhaes Rego, Antônio Roberto Lucena de Araujo
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia. British journal of haematology (2022)
Yanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, Elsa Bernard, Ian Thomas, Amanda Gilkes, Sylvie D Freeman, Yoann Pradat, Sean J Johnson, Robert Hills, Richard Dilon, Max Fine Levine, Daniel A Leongamornlert, Adam Butler, Arnold Ganser, Lars Bullinger, Konstanze Döhner, Oliver Ottmann, Richard A Adams, Hartmut Döhner, Peter J Campbell, Alan K Burnett, Michael Dennis, Nigel H Russell, Sean M Devlin, Brian James Patrick Huntly, Elli Papaemmanuil
Unified classification and risk-stratification in Acute Myeloid Leukemia. Nature communications 13 (1) (2022)
Ing Soo Tiong, Richard Dilon, Adam Ivey, James A Kuzich, Nisha Thiagarajah, Kirsty M Sharplin, Chung Hoow Kok, Aditya Tedjaseputra, James P Rowland, Carolyn S Grove, Emad Abro, Jake Shortt, Devendra K Hiwase, Ashish Bajel, Nicola E Potter, Matthew L Smith, Claire J Hemmaway, Abin Thomas, Amanda F Gilkes, Nigel H Russell, Andrew H Wei
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia. Blood advances 5 (23) (2022)
Priyanka Mehta, Nick Telford, Chris Wragg, Richard Dilon, Sylvie D Freeman, Damian Finnegan, Angela Hamblin, Mhairi Copland, Steve Knapper
A British Society for Haematology good practice paper: Recommendations for laboratory testing of UK patients with acute myeloid leukaemia. British journal of haematology (2022)
Richard Dilon, Robert K Hills, Alan K Burnett, Nigel H Russell
Gemtuzumab ozogamicin in (KMT2A)-rearranged adult acute myeloid leukaemia (AML) in the UK Medical Research Council AML15 and AML16 trials. British journal of haematology (2021)
Richard Dilon, Matthew J Ahearne, Lynn Quek, Nicola Potter, Jelena Jovanovic, Nicola Foot, Mikel Valganon, Sandrine Jayne, Mike Dennis, Kavita Raj, Sudhir Tauro, Martin J S Dyer, Nigel Russell, Ellen Solomon, David Grimwade
Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis. Leukemia 35 (8) (2021)
Michael Heuser, Sylvie D Freeman, Gert J Ossenkoppele, Francesco Buccisano, Christopher S Hourigan, Lok Lam Ngai, Jesse Marc Tettero, Costa Bachas, Constance Baer, Marie Christine Bene, Veit L Bücklein, Anna Czyz, Barbara Denys, Richard Dilon, Michaela Feuring-Buske, Monica L Guzman, Torsten Haferlach, Lina Han, Julia K Herzig, Jeffrey L Jorgensen, Wolfgang Kern, Marina Y Konopleva, Francis Lacombe, Marta Libura, Agata Majchrzak, Luca Maurillo, Yishai Ofran, Jan Philippé, Adriana Plesa, Claude Preudhomme, Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A van de Loosdrecht, Bert A van der Reijden, Adriano Venditti, Agnieszka Świątek, Peter J M Valk, Brent L Wood, Roland Bruno Walter, Christian Thiede, Konstanze Döhner, Gail J Roboz, Jacqueline Cloos
2021 Update Measurable Residual Disease in Acute Myeloid Leukemia: European LeukemiaNet Working Party Consensus Document. Blood (2021)
Thomas Coats, Daniel Bean, Aymeric Basset, Tamir Sirkis, Jonathan Brammeld, Sean Johnson, Ian Thomas, Amanda Gilkes, Kavita Raj, Mike Dennis, Steve Knapper, Priyanka Mehta, Asim Khwaja, Hannah Hunter, Sudhir Tauro, David Bowen, Gail Jones, Richard Dobson, Nigel H Russell, Richard Dilon
A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemia. British journal of haematology 196 (6) (2021)
Ing Soo Tiong, Richard Dilon, Adam Ivey, Tse-Chieh Teh, Phillip Nguyen, Nicholas Cummings, David C Taussig, Annie-Louise Latif, Nicola E Potter, Manohursingh Runglall, Nigel H Russell, Kavita Raj, Anthony P Schwarer, Chun Yew Fong, Andrew P Grigg, Andrew H Wei
Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemia. British journal of haematology 192 (6) (2020)
Charles F Craddock, Aimee Jackson, Justin Loke, Shamyla Siddique, Andrea Hodgkinson, John Mason, Georgia Andrew, Sandeep Nagra, Ram Malladi, Andrew Peniket, Maria H Gilleece, Rahuman Salim, Eleni Tholouli, Victoria Potter, Charles Crawley, Keith Wheatley, Rachel Protheroe, Paresh Vyas, Ann Hunter, Anne Parker, Keith Wilson, Jiří Pavlů, Jennifer L Byrne, Richard Dilon, Naeem Khan, Sylvie D Freeman, Sylvie D Freeman
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2020)
Sheng Li, Francine E Garrett-Bakelman, Stephen S Chung, Mathijs A Sanders, Todd Hricik, Franck Rapaport, Jay Patel, Richard Dilon, Priyanka Vijay, Anna L Brown, Alexander E Perl, Joy Cannon, Lars Bullinger, Selina Luger, Michael Becker, Ian D Lewis, Luen Bik To, Ruud Delwel, Bob Löwenberg, Hartmut Döhner, Konstanze Döhner, Monica L Guzman, Duane C Hassane, Gail J Roboz, David Grimwade, Peter J M Valk, Richard J D'Andrea, Martin Carroll, Christopher Y Park, Donna S Neuberg, Ross Levine, Ari M Melnick, Christopher E Mason
Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia. Nature medicine 22 (7) (2016)

Richard Dilon.css-eqlu8i{font-size:small;padding-left:4px;} (Richard Dillon)

Publication Activity (10 Years)

Top Topics

Top Venues

Richard Dilon (Richard Dillon)